Is Exenatide safe?
Median 3.2 years of safety data
Nausea is the most common side effect. A large minority of patients feel it early in treatment. Vomiting and diarrhea are less common. The weekly form causes lumps at the injection site in many patients. The microsphere carrier is the cause. The label carries a boxed warning for thyroid C-cell tumors seen in rodents. It also warns about pancreatitis and kidney injury from dehydration. It warns about low blood sugar with sulfonylureas or insulin. Allergic reactions are possible too. The kidney clears exenatide. So it is not recommended in severe kidney disease. Over three years, EXSCEL found no extra cases of pancreatitis, pancreatic cancer or medullary thyroid cancer. 18
EXSCEL enrolled 14,752 patients. It showed no rise in cardiovascular events over three years and a trend toward fewer. So exenatide is seen as safe for the heart. But it has no approved use for heart benefit. 8
More on Exenatide
Citations
- FDA 2024: Bydureon BCise (exenatide extended-release) prescribing information accessdata.fda.gov
- Furman 2012, Toxicon: the development of Byetta (exenatide) from the venom of the Gila monster pubmed.ncbi.nlm.nih.gov
- UnitedHealthcare 2024: discontinuation of Bydureon BCise and Byetta uhcprovider.com
- Pi-Sunyer 2015, NEJM: a randomized controlled trial of liraglutide in weight management (SCALE) doi.org
- Wilding 2021, NEJM: once-weekly semaglutide in adults with overweight or obesity (STEP 1) doi.org
- Jastreboff 2022, NEJM: tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) doi.org
- FDA 2025: Mounjaro (tirzepatide) prescribing information accessdata.fda.gov
- Holman 2017, NEJM: effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes (EXSCEL) doi.org
Reference information only, not medical advice. Drawn from the Exenatide article, fact-checked against the cited sources. No dosing anywhere on this site.